Compare First Trust NASDAQ Cybersecurity ETF (CIBR) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Trust NASDAQ Cybersecurity ETF vs Recursion Pharmaceuticals Inc — how do they compare? First Trust NASDAQ Cybersecurity ETF trades at $95.05, while Recursion Pharmaceuticals Inc trades at $3.37 (market cap $1.75B). The key difference: First Trust NASDAQ Cybersecurity ETF is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CIBR | RXRX | |
|---|---|---|
52-Week High | $94.73 | $6.79 |
52-Week Low | $60.74 | $2.84 |
Market Cap | — | $1.75B |
Sector | — | Health |
Enterprise Value | — | $1.17B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About First Trust NASDAQ Cybersecurity ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index includes securities of companies classified as cyber security companies. The fund is non-diversified.
Read more on CIBR →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
